Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yuya Hanashima"'
Autor:
Kentaro Oyama, Yuya Hanashima, Shun Yamamuro, Takuma Nishide, Genki Yazawa, Yoshinari Ozawa, Takahiro Kumagawa, Koichiro Sumi, Atsuo Yoshino
Publikováno v:
Journal of Nihon University Medical Association. 82:55-60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2370f87674044a741594040381b84430
https://doi.org/10.4264/numa.82.1_55
https://doi.org/10.4264/numa.82.1_55
Autor:
Sota Takechi, Takahiro Kumagawa, Takeshi Suma, Takuma Nishide, Ryo Kajiwara, Ryoji Shiokawa, Yuya Hanashima, Shun Yamamuro, Atsuo Yoshino
Publikováno v:
Japanese Journal of Stroke. 44:425-430
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de0de131bdcb2364268f945ecfce68a7
https://doi.org/10.3995/jstroke.10985
https://doi.org/10.3995/jstroke.10985
Introduction of R-MPV Therapy for Primary Central Nervous System Lymphoma:A Report of Our Experience
Publikováno v:
Journal of Nihon University Medical Association. 80:225-231
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5765b6ff18bef9d9da30b9096aabafc
https://doi.org/10.4264/numa.80.5_225
https://doi.org/10.4264/numa.80.5_225
Autor:
Takuma Nishide Nishide, Shun Yamamuro, Yoshinari Ozawa, Genki Yazawa, Yuya Hanashima, Koichiro Sumi, Atsuo Yoshino
Publikováno v:
Journal of Nihon University Medical Association. 80:253-257
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b487ede321a4aa3cb8bf0ef51da1d26
https://doi.org/10.4264/numa.80.5_253
https://doi.org/10.4264/numa.80.5_253
Autor:
Chihiro Yagi, Juri Tatsuoka, Emiko Sano, Yuya Hanashima, Yoshinari Ozawa, Sodai Yoshimura, Shun Yamamuro, Koichiro Sumi, Hiroyuki Hara, Yoichi Katayama, Atsuo Yoshino
Publikováno v:
Oncology reports. 48(6)
Patients with glioblastoma frequently suffer epileptic seizures and often require anticonvulsant therapy during the treatment course. The present study investigated four common antiepileptic drugs, perampanel, carbamazepine (CBZ), sodium valproate (V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a60fc5d3c2c4110027387b8f8431afc
https://pubmed.ncbi.nlm.nih.gov/36281939
https://pubmed.ncbi.nlm.nih.gov/36281939
Autor:
Tomohiro Nakayama, Shun Yamamuro, Yutaka Suzuki, Yuya Hanashima, Juri Tatsuoka, Hiroyuki Hara, Sodai Yoshimura, Koichiro Sumi, Yoshinari Ozawa, Emiko Sano, Atsuo Yoshino
Publikováno v:
Biochemical and Biophysical Research Communications. 524:723-729
Recent research has revealed that glioblastoma (GBM) avoids the immune system via strong expression of indoleamine 2,3-dioxygenase 1 (IDO1). IDO1, an enzyme involved in tryptophan metabolism, is now proposed as a new target in GBM treatment, since se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c629538238dfce7e4101211a83e0bb5c
https://doi.org/10.1016/j.bbrc.2020.01.148
https://doi.org/10.1016/j.bbrc.2020.01.148
Autor:
Akira Kazaana, Yoshinari Ozawa, Yutaka Suzuki, Toshiaki Takei, Sodai Yoshimura, Hisashi Tadakuma, Emiko Sano, Atsuo Yoshino, Yuya Hanashima, Takuya Ueda
Publikováno v:
Biochimica et biophysica acta. Molecular cell research. 1868(7)
Interleukin-6 (IL-6) enhanced TNF-α and TRAIL/Apo2L induced cell death in various human cancer cells derived from malignant glioma, melanoma, breast cancer and leukemia, although the effect was not detected with IL-6 alone. The effects of IL-6 using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4d2e461253100c23e37516951c0d16
https://pubmed.ncbi.nlm.nih.gov/33839168
https://pubmed.ncbi.nlm.nih.gov/33839168
Autor:
SHUN YAMAMURO1 shun.yamamuro@nihon-u.ac.jp, YUYA HANASHIMA1, SODAI YOSHIMURA1, HIROYUKI AOKI1, KOKI KAMIYA1, YUSUKE TAKAMINE1, HIROSHI NEGISHI1, ATSUO YOSHINO1
Publikováno v:
Molecular & Clinical Oncology. 2017, Vol. 7 Issue 6, p953-956. 4p.
Autor:
Hideki Oshima, Sumie Ohni, Yuya Hanashima, Sodai Yoshimura, Taku Homma, Yoshiaki Kusumi, Atsuo Yoshino, Shun Yamamuro
Publikováno v:
Neuropathology. 37:371-374
We report here a rare case of symptomatic granular cell tumor (GCT) of the sellar region with a large calcification. A 70-year-old woman presented with a sellar mass, accompanied by bitemporal hemianopia. The patient was diagnosed preoperatively as h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f80ce4da252070ea21ecab27959c6a94
https://doi.org/10.1111/neup.12378
https://doi.org/10.1111/neup.12378
Autor:
Tomohiro Nakayama, Hiroyuki Hara, Atsuo Yoshino, Yuya Hanashima, Koichiro Sumi, Emiko Sano, Yoichi Katayama, Shun Yamamuro, Sodai Yoshimura, Takuya Ueda
Publikováno v:
Oncology Reports
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of the tumor necrosis factor (TNF) family, induces apoptosis in cancer cells by binding to its receptors, death receptor 4 (DR4) and DR5, without affecting normal cells, and is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f31a6d4759b96d28164b1983c6d935
https://doi.org/10.3892/or.2019.7383
https://doi.org/10.3892/or.2019.7383